Ablation of Atrial Fibrillation: Clinical Trials

1 trial for Ablation of Atrial Fibrillation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Not yet recruiting 1
Phase 21Not yet recruiting 1

Follow Ablation of Atrial Fibrillation: new trials by email Literature Review of Ablation of Atrial Fibrillation trials Research Report on Ablation of Atrial Fibrillation

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Relaxin Therapy for Atrial Fibrillation
Relaxin, Placebo - Atrial Fibrillation (AF), Arrhythmia
Phase 1 / Phase 2Not yet recruitingDeeptankar DeMazumder2082027-01-012026-01-22

Narrower conditions

Arrhythmias, Cardiac (1)  ·  Atrial Fibrillation (1)  ·  Heart Failure (1)  ·  Stroke (1)

Broader conditions

Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Heart Diseases (1)  ·  Nervous System Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Vascular Diseases (1)

Interventions

Relaxin (1)

Sponsors

Deeptankar DeMazumder (1)

Top investigators

Deeptankar DeMazumder, MD, PhD (1)